(Hypertension. 1999;33:998-1001.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Blood Pressure (T.F.T.A., N.D.M., G.A.M.) and Dermatology (P.S.M.) Units, Department of Medicine, and the Clinical Pharmacology Unit (T.F.T.A., D.R.J.S.), Department of Pharmacology and Clinical Pharmacology, St George's Hospital Medical School, London, UK.
Correspondence to Dr Tarek F.T. Antonios, Clinical Pharmacology Unit, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK. E-mail t.antonios{at}sghms.ac.uk
| Abstract |
|---|
|
|
|---|
Key Words: hypertension, essential microcirculation capillaries vascular resistance rarefaction
| Introduction |
|---|
|
|
|---|
The aim of this study was to assess whether rarefaction of capillaries in hypertension is a structural or functional defect by examining capillary density in the skin of the dorsum of fingers under resting conditions and after maximizing the number of perfused capillaries.
| Methods |
|---|
|
|
|---|
Intravital Capillaroscopy
Video microscopy with an epi-illuminated microscope containing a
100-W mercury vapor lamp light source and a PL 6.3/0.2 objective
(Wild-Leitz type 307143.004, Leica UK Ltd), final magnification of
x196, was used. Microscopic images were recorded on a CCD camera
(Hitachi, model CCD HV-725K) and transferred using a video scalar
(VS-1000) and video timer (For-A VTG 33) for storage onto a video
recorder (Panasonic model AUC 7350). The skin of the dorsum of
middle phalanx of the nondominant (left) hand was examined. Four
microscopic fields (0.68 mm2 each) centered
around an ink spot were recorded continuously for 5 minutes to
detect intermittently perfused capillaries. Still-frame video prints
(Sony multiscan video printer UP-930) obtained from each recorded
field were analyzed offline. The number of capillaries per
field was counted by hand from these prints as well as from live
playback of the recorded tapes. Skin temperature was monitored
throughout the study with a temperature probe on the dorsum of the left
index finger (YSI Tele-thermometers). Patients with cold hands were
excluded from the study.
Maximization of Skin Capillaries Visualized
Different techniques have been used previously to maximize the
number of skin capillaries visualized during dynamic capillaroscopy. In
a separate study, we examined 33 subjects 21 to 68 years of age (16
men, 17 women) to compare the effects of venous congestion versus
postocclusive reactive hyperemia on skin capillary density.
Venous Congestion
The enhancing effect of venous congestion on the visualization
of skin capillaries by video microscopy has been previously
reported.10 11 12 Venous congestion maximizes the number of
visualized capillaries by increasing their red cell content. A
miniature BP cuff was applied to the base of the left middle finger,
the cuff was inflated and maintained at 60 mm Hg for 2 minutes,
and further images were recorded using 1 of the 4 microscopic
fields, chosen at random.
Reactive Hyperemia
This produces a vasodilative response mediated by myogenic
and/or local chemical factors. We applied 2 different techniques.
First, arterial blood flow into the forearm and hand was
stopped for 3 minutes by inflating a sphygmomanometer cuff to 200
mm Hg. Second, we inflated a miniature cuff applied to the base of the
middle finger and again stopped arterial blood flow in the
finger for 5 minutes by inflating the cuff to 200 mm Hg. In both
cases, the cuff was deflated abruptly by breaking the connection, and,
subsequently, capillaroscopic images were obtained continuously for 2
minutes.
The results showed that the baseline mean skin capillary density of the dorsum of finger was 76±2/0.68 mm2. With venous occlusion, capillary density increased to 84±3/0.68 mm2, and with reactive hyperemia it dropped to 71±3/0.68 mm2 (P<0.0001; ANOVA) (Figure 1). These results clearly show that when using intravital capillary video microscopy venous congestion maximizes the number of visualized capillaries more significantly than does postocclusion reactive hyperemia. It is well known that capillary blood-cell velocity (CBV) increases with postocclusive reactive hyperemia.13 14 With reactive hyperemia the number of capillaries showing active flow motion increased.15 Given these last 2 findings, it may not be surprising that fewer capillaries were visible during reactive hyperemia than with venous congestion.
|
Blood Pressure and Heart Rate
Blood pressure was measured with a semiautomatic ultrasound
sphygmomanometer (Arteriosonde, Roche) with appropriate cuff size.
Supine blood pressure was taken as the mean of 3 readings obtained at
1- to 2-minute intervals with the patient supine. Body weight was
recorded in the morning after the patient voided and with each
patient wearing indoor clothing and no shoes.
Blood Analysis
Venous blood was taken without stasis after the patient had been
sitting upright for 10 minutes. Variables measured included serum
electrolytes, urea, creatinine, uric acid, glucose, total
cholesterol, triglycerides, and full blood
count.
Statistical Analysis
All results are given as mean±SE. The data were processed by
use of StatView 4.0 software (Abacus Concepts, Inc). ANOVA for repeated
measurements was used to compare groups. P<0.05 was
considered statistically significant.
| Results |
|---|
|
|
|---|
|
Mean capillary density at baseline (before venous congestion) was significantly lower (17%) in the hypertensive subjects than in the normotensive controls (62±4 versus 73±5 capillaries per 0.68 mm2 respectively) (P=0.049; ANOVA) (Figure 2). With venous occlusion, capillary density increased significantly in both groups; however, maximal capillary density was significantly lower (19%) in the hypertensive subjects (73±5 capillaries per field in the hypertensives) compared with 87±4 capillaries per field in the normotensives (P=0.0325; ANOVA) (Figure 2).
|
| Discussion |
|---|
|
|
|---|
Venous occlusion (congestion) during capillaroscopy enhances the visualization of red cellfilled capillaries and allows the trapping of red cells in plasma-only perfused capillaries as well as intermittently perfused capillaries. The enhancing effect of venous congestion on the visualization of capillaries has been used in many previous studies.11 12 The venous backpressure reduces the pressure gradient driving flow, which by temporarily reducing flow and washout of vasodilators causes vasodilatation.16 Prolonged venous occlusion on the other hand, could increase precapillary resistance through the venoarteriolar response.17 However, this response is noted in the dependent parts of the body and is known to be reduced in patients with essential hypertension compared with healthy volunteers.18 Furthermore, in our study, we examined the capillaries with the hand held at heart level, which abolishes the effects of this reflex.
Are Capillaries Resistance Vessels?
The resistance increase in hypertension is believed to be
localized primarily in the small arteries and in the microcirculation
(arterioles, venules, and capillaries). The relative contribution of
these 2 segments of the vascular system to the resistance increase may
vary from tissue to tissue. Small differences in vessel number, length,
diameter and branching characteristics may be sufficient to shift
pressure and flow distribution in particular tissues.19 In
fact, the pressure drops gradually from the level of the small arteries
to the capillaries without a specific, single site of resistance
control along this segment of the vascular tree.20 Despite
their thin walls, capillaries are relatively
nondistensible21 and their endothelial
cell nuclei encroach on the lumen to reduce luminal cross-sectional
area by
50%.22 23 These deformations are accompanied by
a slowing or diversion of the blood stream to other vessels. Capillary
endothelial cells in mammals also have been shown to
contain actin filaments and heavy meromyosin, which may indicate some
form of contractility.24 The capillary
network thus can contribute to the resistance control by virtue of
their narrow caliber, by the reduction in their number (rarefaction),
or possibly through their deformations.
Capillary Rarefaction
Capillary rarefaction has been described in various tissues from
patients with essential hypertension not only in the established
phase2 4 7 25 but also in early phases of hypertension,
with only intermittent elevations of blood pressure.26
Recently, with the introduction of intravital video microscopy, a 15%
to 20% reduction in the capillary density of the nail-fold skin
capillaries was found.8 Recently, our own group using
intravital fluorescein angiography, found a similar 20%
reduction in capillary density in the forearm skin of hypertensive
subjects compared with normotensive subjects.9
Furthermore, in that study, there was a significant negative
correlation between capillary density and systolic blood
pressure in patients with essential hypertension. In this present
study, there is a significant negative correlation between
systolic blood pressure and capillary density for the whole
group, but this correlation did not reach statistical significance in
the hypertensive group, probably as a result of the narrow range of
blood pressures in the hypertensive subjects compared with the previous
study.
Much evidence now indicates that microvascular rarefaction could be an important mechanism in the pathogenesis of human essential hypertension, as first suggested by Hutchins and Darnell.5 Recently, Greene et al27 used a mathematical model of the hamster cheek-pouch intraluminal microcirculation to perform separate simulations of rarefaction and constriction of small arterioles. Their results showed that vessel rarefaction up to 42% (within the range observed in hypertensive humans or animals) can increase tissue resistance by 21%, an amount comparable to vessel constriction.27
Several mechanisms have been proposed to explain microvascular rarefaction in hypertension. Rarefaction may be either structural, associated with impaired angiogenesis or capillary apoptosis (attrition), or functional, associated with impaired recruitment of nonperfused capillaries. The concept of functional versus structural rarefaction was first developed by Prewitt and coworkers.28 They proposed that in hypertension, arterioles first undergo functional rarefaction and then structural rarefaction. They postulated that functional rarefaction is caused by microvascular constriction to the point of nonperfusion of the vessel, whereas structural rarefaction represents a true anatomical absence of the vessels. However, their theory cannot explain structural rarefaction observed in very early stages of hypertension in spontaneously hypertensive rats. It is yet not clear whether the reduction in capillary density is primary or secondary to the hypertension. Recently, Noon et al11 studied subjects from a novel, 4-corners epidemiological model, in which subjects were identified as having either high or low blood pressure in early adulthood and were further classified on the basis of their parents' blood pressures. They found that offspring with high blood pressure whose parents also had high blood pressure had fewer capillaries on the dorsum of fingers, suggesting that defective angiogenesis may be a causal component in the inheritance of high blood pressure.11 Structural rarefaction of capillaries, on the other hand, may support the theory of reduced angiogenesis and diminished microvascular growth in primary hypertension. Depressed angiogenesis can be caused by genetic influences or by autoregulatory mechanisms. The potential genetic mechanisms are still unknown, although recently the spontaneously hypertensive rat genetic abnormality has been localized in a chromosomal domain that also contains growth-related hormones and elements of the renin-angiotensin system.29 30
In conclusion, this study demonstrates that maximal capillary density with venous occlusion is significantly lower in hypertensive subjects than in normotensive controls. This strongly suggests that much of the reduction in capillary density in hypertension is due to the anatomic absence of capillaries rather than their functional reduction.
| Acknowledgments |
|---|
Received October 5, 1998; first decision November 6, 1998; accepted November 24, 1998.
| References |
|---|
|
|
|---|
2. Lack A. Biomicroscopy of conjunctival vessels in hypertension. Am Heart J. 1949;38:654664.[Medline] [Order article via Infotrieve]
3. Williams SA, Boolell M, MacGregor GA, Smaje LH, Wasserman SM, Tooke JE. Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension. Clin Sci. 1990;79:58.[Medline] [Order article via Infotrieve]
4. Harper RN, Moore MA, Marr MC, Watts LE, Hutchins PM. Arteriolar rarefaction in the conjunctiva of human essential hypertensives. Microvasc Res. 1978;16:369372.[Medline] [Order article via Infotrieve]
5. Hutchins PM, Darnell AE. Observation of a decreased number of small arterioles in spontaneously hypertensive rats. Circ Res. 1974;34(suppl 1):161165.
6. Chen IH, Prewitt RL, Dowell RF. Microvascular rarefaction in spontaneously hypertensive rat cremaster muscle. Am J Physiol. 1981;241:H306H310.
7.
Ruedemann AD. Conjunctival vessels. JAMA. 1933;101:14771481.
8. Gasser P, Buhler FR. Nailfold microcirculation in normotensive and essential hypertensive subjects, as assessed by video-microscopy. J Hypertens. 1992;10:8386.[Medline] [Order article via Infotrieve]
9. Prasad A, Dunnill GS, Mortimer PS, MacGregor GA. Capillary rarefaction in the forearm skin in essential hypertension. J Hypertens. 1995;13:265268.[Medline] [Order article via Infotrieve]
10. Wetzel NC, Zotterman Y. On differences in the vascular colouration of various regions of the normal human skin. Heart. 1926;13:357369.
11. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest. 1997;99:18731879.[Medline] [Order article via Infotrieve]
12. Roberts CC, Stanton AW, Pullen J, Bull RH, Levick JR, Mortimer PS. Skin microvascular architecture and perfusion studied in human postmastectomy oedema by intravital video-capillaroscopy. Int J Microcirc Clin Exp. 1994;14:327334.[Medline] [Order article via Infotrieve]
13. Ostergren J, Svedman P, Fagrell B. The influence of venous and arterial occlusion on capillary blood flow and transcutaneous oxygen tension in fingers. Int J Microcirc Clin Exp. 1983;2:315324.[Medline] [Order article via Infotrieve]
14. Bollinger A, Hoffmann U, Franzeck UK. Microvascular changes in arterial occlusive disease: target for pharmacotherapy. Vasc Med. 1996;1:5054.[Medline] [Order article via Infotrieve]
15. Seifert H, Jager K, Bollinger A. Analysis of flow motion by the laser Doppler technique in patients with peripheral arterial occlusive disease. Int J Microcirc Clin Exp. 1988;7:223236.[Medline] [Order article via Infotrieve]
16. Levick JR. In: An Introduction to Cardiovascular Physiology. 2nd ed. Oxford, UK: Butterworth-Heinemann; 1996.
17. Cesarone MR, Laurora G, De Sanctis MT, Incadella L, Marelli C, Belcaro G. Skin blood flow and veno-arteriolar response in essential hypertension. Minerva Cardioangiol. 1992;40:115119.[Medline] [Order article via Infotrieve]
18. Cesarone MR, Laurora G, De Sanctis MT, Incandela L, Belcaro G. Skin flux and the venoarteriolar response in essential hypertension. Panminerva Med. 1993;35:58.[Medline] [Order article via Infotrieve]
19. Zweifach BW, Lipowsky HH. Pressure-flow relations in blood and lymph circulation. In: Geiger SR, ed. Handbook of Physiology-The Cardiovascular System. Bethesda, Md: American Physiological Society; 1983:251307.
20. Struijker-Boudier HAJ. Vascular growth and hypertension. In: Laragh JH, Brenner BM, eds. HypertensionPathophysiology, Diagnosis, and Management. New York, NY: Raven Press; 1995:200213.
21. Fung YC. Structural mechanics of microvasculature. In: Gross J, Popel A, eds. Mathematics of Microcirculation Phenomena. New York, NY: Raven; 1979:116.
22. McCusky RS. Sphincters in the microvascular system. Microvasc Res. 1971;2:428433.
23. Kuwakabra J, Kogan DG. Retinal vascular patterns in mural cells of the retinal capillaries. Arch Ophthalmol. 1963;69:492592.
24. Brecker CG, Shustak SR. Contractile proteins in endothelial cells: comparison of cerebral capillaries with those in heart and skeletal muscle and with liver sinusoids. Circulation. 1972;45/46(suppl II):II-87.
25. Lee RE, Holze EA. Peripheral vascular hemodynamics in the bulbar conjunctiva of subjects with hypertensive vascular disease. J Clin Invest. 1951;30:539546.
26.
Sullivan JM, Prewitt RL, Josephs JA. Attenuation of the
microcirculation in young patients with high-output borderline
hypertension. Hypertension. 1983;5:844851.
27. Greene AS, Tonellato PJ, Lui J, Lombard JH, Cowley AW Jr. Microvascular rarefaction and tissue vascular resistance in hypertension. Am J Physiol. 1989;256(pt 2):H126H131.
28. Prewitt RL, Hashimoto H, Stacy DL. Structural and functional rarefaction of microvessels in hypertension. In: Lee R, ed. Blood Vessel Changes in Hypertension: Structure and Function. Boca Raton, Fla: CRC Press; 1990:7190.
29. Hilbert P, Lindpaintner K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, Cartwright P, De Gouyon B, Julier C, Takahasi S. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature. 1991;353:521529.[Medline] [Order article via Infotrieve]
30. Jacob HJ, Lindpaintner K, Lincoln SE, Kusumi K, Bunker RK, Mao YP, Ganten D, Dzau VJ, Lander ES. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell. 1991;67:213224.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
B. I. Levy Blood pressure as a potential biomarker of the efficacy angiogenesis inhibitor Ann. Onc., February 1, 2009; 20(2): 200 - 203. [Full Text] [PDF] |
||||
![]() |
C. Cheng, C. Daskalakis, and B. Falkner Original Research: Capillary rarefaction in treated and untreated hypertensive subjects Therapeutic Advances in Cardiovascular Disease, April 1, 2008; 2(2): 79 - 88. [Abstract] [PDF] |
||||
![]() |
F. Feihl, L. Liaudet, B. Waeber, and B. I. Levy Hypertension: A Disease of the Microcirculation? Hypertension, December 1, 2006; 48(6): 1012 - 1017. [Full Text] [PDF] |
||||
![]() |
M. A. James, J. Tullett, A. G. Hemsley, and A. C. Shore Effects of Aging and Hypertension on the Microcirculation Hypertension, May 1, 2006; 47(5): 968 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Crowley, S. Gurley, M. Oliverio, A. Pazmino, R Griffiths, P. Flannery, R. Spurney, H-S Kim, O Smithies, T. Le, et al. Is the Kidney Always the Cause of Hypertension?: Distinct Roles for the Kidney and Systemic Tissues in Blood Pressure Regulation by the Renin-Angiotensin System. J Clin Invest 115: 1092-1099, 2005 J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1525 - 1532. [Full Text] [PDF] |
||||
![]() |
M.-L. Gross, K. Amann, and E. Ritz Nephron Number and Renal Risk in Hypertension and Diabetes J. Am. Soc. Nephrol., March 1, 2005; 16(3_suppl_1): S27 - S29. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Srivastava, R. L. Terjung, and H. T. Yang Basic fibroblast growth factor increases collateral blood flow in spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1190 - H1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
T F T Antonios, F M Rattray, D R J Singer, N D Markandu, P S Mortimer, and G A MacGregor Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension Heart, February 1, 2003; 89(2): 175 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.J Irving, B.R Walker, J.P Noon, G.C.M Watt, D.J Webb, and A.C Shore Microvascular correlates of blood pressure, plasma glucose, and insulin resistance in health Cardiovasc Res, January 1, 2002; 53(1): 271 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.I. Levy, G. Ambrosio, A.R. Pries, and H.A.J. Struijker-Boudier Microcirculation in Hypertension: A New Target for Treatment? Circulation, August 1, 2001; 104(6): 735 - 740. [Full Text] [PDF] |
||||
![]() |
E. H. Serne, R. O.B. Gans, J. C. ter Maaten, G.-J. Tangelder, A. J.M. Donker, and C. D.A. Stehouwer Impaired Skin Capillary Recruitment in Essential Hypertension Is Caused by Both Functional and Structural Capillary Rarefaction Hypertension, August 1, 2001; 38(2): 238 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.F.T Antonios, J.C Kaski, K.M Hasan, S.J Brown, and D.R.J Singer Rarefaction of skin capillaries in patients with anginal chest pain and normal coronary arteriograms Eur. Heart J., July 1, 2001; 22(13): 1144 - 1148. [Abstract] [PDF] |
||||
![]() |
C. Emanueli, M. B. Salis, T. Stacca, L. Gaspa, J. Chao, L. Chao, A. Piana, and P. Madeddu Rescue of Impaired Angiogenesis in Spontaneously Hypertensive Rats by Intramuscular Human Tissue Kallikrein Gene Transfer Hypertension, July 1, 2001; 38(1): 136 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H Serne, R. O.B Gans, J. C ter Maaten, P. M ter Wee, A. J.M Donker, and C. D.A Stehouwer Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions Cardiovasc Res, January 1, 2001; 49(1): 161 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Yan, M. Moses, S Huang, and D. Ingber Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells J. Cell Sci., January 11, 2000; 113(22): 3979 - 3987. [Abstract] [PDF] |
||||
![]() |
T. F. T. Antonios, D. R. J. Singer, N. D. Markandu, P. S. Mortimer, and G. A. MacGregor Rarefaction of Skin Capillaries in Borderline Essential Hypertension Suggests an Early Structural Abnormality Hypertension, October 1, 1999; 34(4): 655 - 658. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |